Skip to content

Clinical trials

Phase 1/2 Respiratory Distress Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Phase: Phase 1/2 Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20111
20161
20207
20214
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated2
Unknown status2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AVEM HealthCare1
Apellis Pharmaceuticals, Inc.1
Baylor College of Medicine1
Camillo Ricordi1
Eli Lilly and Company1
FDA Office of Orphan Products Development1
Healios K.K.1
Hunter Holmes Mcguire Veteran Affairs Medical Center1
Joanne Kurtzberg, MD1
Mirror Biologics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome17
COVID-1912
Coronavirus Infections6
Acute Lung Injury5
Pneumonia3
Hypoxia2
Respiratory Insufficiency2
Severe Acute Respiratory Syndrome2
Bronchiolitis Obliterans1
Cytokine Release Syndrome1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.